These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 27189967)
1. Preferential Delivery of an Opioid Antagonist to the Fetal Brain in Pregnant Mice. Oberdick J; Ling Y; Phelps MA; Yudovich MS; Schilling K; Sadee W J Pharmacol Exp Ther; 2016 Jul; 358(1):22-30. PubMed ID: 27189967 [TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice. Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384 [TBL] [Abstract][Full Text] [Related]
3. 6β-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study. Yancey-Wrona J; Dallaire B; Bilsky E; Bath B; Burkart J; Webster L; Magiera D; Yang X; Phelps M; Sadee W Pain Med; 2011 Dec; 12(12):1727-37. PubMed ID: 22123184 [TBL] [Abstract][Full Text] [Related]
4. Mu-opioid receptor up-regulation and functional supersensitivity are independent of antagonist efficacy. Sirohi S; Kumar P; Yoburn BC J Pharmacol Exp Ther; 2007 Nov; 323(2):701-7. PubMed ID: 17698975 [TBL] [Abstract][Full Text] [Related]
5. The role of opioid antagonist efficacy and constitutive opioid receptor activity in the opioid withdrawal syndrome in mice. Navani DM; Sirohi S; Madia PA; Yoburn BC Pharmacol Biochem Behav; 2011 Oct; 99(4):671-5. PubMed ID: 21736895 [TBL] [Abstract][Full Text] [Related]
6. Comparison of the opioid receptor antagonist properties of naltrexone and 6 beta-naltrexol in morphine-naïve and morphine-dependent mice. Divin MF; Holden Ko MC; Traynor JR Eur J Pharmacol; 2008 Mar; 583(1):48-55. PubMed ID: 18275956 [TBL] [Abstract][Full Text] [Related]
7. Differential in vivo potencies of naltrexone and 6beta-naltrexol in the monkey. Ko MC; Divin MF; Lee H; Woods JH; Traynor JR J Pharmacol Exp Ther; 2006 Feb; 316(2):772-9. PubMed ID: 16258020 [TBL] [Abstract][Full Text] [Related]
8. 6beta-naltrexol preferentially antagonizes opioid effects on gastrointestinal transit compared to antinociception in mice. Yancey-Wrona JE; Raymond TJ; Mercer HK; Sadée W; Bilsky EJ Life Sci; 2009 Sep; 85(11-12):413-20. PubMed ID: 19583969 [TBL] [Abstract][Full Text] [Related]
9. Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys. Li JX; McMahon LR; France CP Psychopharmacology (Berl); 2008 Jan; 195(4):479-86. PubMed ID: 17874317 [TBL] [Abstract][Full Text] [Related]
10. In vivo characterization of the opioid antagonist nalmefene in mice. Osborn MD; Lowery JJ; Skorput AG; Giuvelis D; Bilsky EJ Life Sci; 2010 Apr; 86(15-16):624-30. PubMed ID: 20159022 [TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro potency studies of 6beta-naltrexol, the major human metabolite of naltrexone. Porter SJ; Somogyi AA; White JM Addict Biol; 2002 Apr; 7(2):219-25. PubMed ID: 12006217 [TBL] [Abstract][Full Text] [Related]
12. A clinical trial to determine if corelease of morphine and naltrexone from crushed extended-release capsules induces withdrawal in opioid-dependent patients: a descriptive analysis of six patients. Setnik B; Roland CL; Goli V; Sommerville K; Webster L J Opioid Manag; 2013; 9(2):139-50. PubMed ID: 23709323 [TBL] [Abstract][Full Text] [Related]
13. The relative potency of inverse opioid agonists and a neutral opioid antagonist in precipitated withdrawal and antagonism of analgesia and toxicity. Sirohi S; Dighe SV; Madia PA; Yoburn BC J Pharmacol Exp Ther; 2009 Aug; 330(2):513-9. PubMed ID: 19435929 [TBL] [Abstract][Full Text] [Related]
14. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence. Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological Prevention of Neonatal Opioid Withdrawal in a Pregnant Guinea Pig Model. Safa A; Lau AR; Aten S; Schilling K; Bales KL; Miller VA; Fitzgerald J; Chen M; Hill K; Dzwigalski K; Obrietan K; Phelps MA; Sadee W; Oberdick J Front Pharmacol; 2020; 11():613328. PubMed ID: 33716726 [TBL] [Abstract][Full Text] [Related]
16. Biased Opioid Antagonists as Modulators of Opioid Dependence: Opportunities to Improve Pain Therapy and Opioid Use Management. Sadee W; Oberdick J; Wang Z Molecules; 2020 Sep; 25(18):. PubMed ID: 32932935 [TBL] [Abstract][Full Text] [Related]
17. [Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia]. Yan LD; Gong ZH; Yao XJ; Qin BY Yao Xue Xue Bao; 2003 Aug; 38(8):578-81. PubMed ID: 14628446 [TBL] [Abstract][Full Text] [Related]
18. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice. Crain SM; Shen KF Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296 [TBL] [Abstract][Full Text] [Related]
19. Influence of chronic prenatal and postnatal administration of naltrexone in locomotor activity induced by morphine in mice. Medina Jiménez M; Luján Estrada M; Rodríguez R Arch Med Res; 1997; 28(1):61-5. PubMed ID: 9078589 [TBL] [Abstract][Full Text] [Related]
20. Transplacental transfer of naltrexone in rats. Zagon IS; Hurst WJ; McLaughlin PJ Life Sci; 1997; 61(13):1261-7. PubMed ID: 9324068 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]